Cargando…
Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
BACKGROUND: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because of the complexity of tumor transcriptome, there is a need to look for the molecular signatures which can be used to evaluate the tissue origin and ce...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643977/ https://www.ncbi.nlm.nih.gov/pubmed/37969389 http://dx.doi.org/10.21037/tcr-23-234 |
_version_ | 1785147185366564864 |
---|---|
author | Xiao, Hui Hu, Liang Tan, Qi Jia, Jinping Xie, Ping Li, Junai Wang, Minghua |
author_facet | Xiao, Hui Hu, Liang Tan, Qi Jia, Jinping Xie, Ping Li, Junai Wang, Minghua |
author_sort | Xiao, Hui |
collection | PubMed |
description | BACKGROUND: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because of the complexity of tumor transcriptome, there is a need to look for the molecular signatures which can be used to evaluate the tissue origin and cell stemness of tumors in order to promote the diagnosis and treatment of tumors. METHODS: Tumor tissue-specific gene sets (TTSGs) consisting of 200 genes were selected using RNA expression data of 9,875 patients from 33 tumor types. t-distributed Stochastic Neighbor Embedding (t-SNE) was used for dimensionality reduction and visualization of TTSGs in each tumor type. To evaluate oncogenic dedifferentiation and loss of cell stemness, Euclidean distance from each sample to a human embryo single-cell RNA-seq dataset (GSE36552) of TTSGs was calculated as TTSGs index indicating dissimilarity of tumors and embryo. TTSGs index was evaluated for prognosis in each tumor type. Two published signature indexes, the mRNA signature index (mRNAsi) and CIBERSORT, were compared to assess the correlation between the TTSGs index with cell stemness and immune microenvironment. Finally, the difference of prognosis, immune microenvironment and radiotherapy outcomes were compared between patients with high and low TTSGs index. RESULTS: In this study, all 33 tumor types in The Cancer Genome Atlas (TCGA) were embedded into isolated clusters by t-SNE and confirmed by k-nearest neighbors (kNN) algorithm. Clusters of squamous-cell carcinoma were adjacent to each other revealing similar histologic origin. Basal-like breast cancer was separated from luminal and HER-2-amplified subtypes and closed to squamous-cell carcinoma. TTSGs index was related to overall survival outcomes in cancers derived from liver, thyroid, brain, cervical and kidney. There was a positive correlation between mRNAsi and TTSGs index in pan-kidney and pan-neuronal cancers. Furthermore, cell fractions of M2 macrophages and total leukocytes increased in the group with higher TTSGs index. Patients with higher TTSGs index had longer overall survival time and less radiation therapy resistance compared to patients with lower TTSGs index. CONCLUSIONS: The signature of TTSGs is related to tumor expression features that distinguish tumors of different histologic origin using t-SNE. The signature also relates to prognosis of certain kinds of tumors. |
format | Online Article Text |
id | pubmed-10643977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-106439772023-11-15 Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types Xiao, Hui Hu, Liang Tan, Qi Jia, Jinping Xie, Ping Li, Junai Wang, Minghua Transl Cancer Res Original Article BACKGROUND: In recent years, with the development of transcriptome sequencing, the molecular characteristics of tumors are gradually revealed. Because of the complexity of tumor transcriptome, there is a need to look for the molecular signatures which can be used to evaluate the tissue origin and cell stemness of tumors in order to promote the diagnosis and treatment of tumors. METHODS: Tumor tissue-specific gene sets (TTSGs) consisting of 200 genes were selected using RNA expression data of 9,875 patients from 33 tumor types. t-distributed Stochastic Neighbor Embedding (t-SNE) was used for dimensionality reduction and visualization of TTSGs in each tumor type. To evaluate oncogenic dedifferentiation and loss of cell stemness, Euclidean distance from each sample to a human embryo single-cell RNA-seq dataset (GSE36552) of TTSGs was calculated as TTSGs index indicating dissimilarity of tumors and embryo. TTSGs index was evaluated for prognosis in each tumor type. Two published signature indexes, the mRNA signature index (mRNAsi) and CIBERSORT, were compared to assess the correlation between the TTSGs index with cell stemness and immune microenvironment. Finally, the difference of prognosis, immune microenvironment and radiotherapy outcomes were compared between patients with high and low TTSGs index. RESULTS: In this study, all 33 tumor types in The Cancer Genome Atlas (TCGA) were embedded into isolated clusters by t-SNE and confirmed by k-nearest neighbors (kNN) algorithm. Clusters of squamous-cell carcinoma were adjacent to each other revealing similar histologic origin. Basal-like breast cancer was separated from luminal and HER-2-amplified subtypes and closed to squamous-cell carcinoma. TTSGs index was related to overall survival outcomes in cancers derived from liver, thyroid, brain, cervical and kidney. There was a positive correlation between mRNAsi and TTSGs index in pan-kidney and pan-neuronal cancers. Furthermore, cell fractions of M2 macrophages and total leukocytes increased in the group with higher TTSGs index. Patients with higher TTSGs index had longer overall survival time and less radiation therapy resistance compared to patients with lower TTSGs index. CONCLUSIONS: The signature of TTSGs is related to tumor expression features that distinguish tumors of different histologic origin using t-SNE. The signature also relates to prognosis of certain kinds of tumors. AME Publishing Company 2023-09-20 2023-10-31 /pmc/articles/PMC10643977/ /pubmed/37969389 http://dx.doi.org/10.21037/tcr-23-234 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Xiao, Hui Hu, Liang Tan, Qi Jia, Jinping Xie, Ping Li, Junai Wang, Minghua Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types |
title | Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types |
title_full | Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types |
title_fullStr | Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types |
title_full_unstemmed | Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types |
title_short | Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types |
title_sort | transcriptional profiles reveal histologic origin and prognosis across 33 the cancer genome atlas tumor types |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643977/ https://www.ncbi.nlm.nih.gov/pubmed/37969389 http://dx.doi.org/10.21037/tcr-23-234 |
work_keys_str_mv | AT xiaohui transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes AT huliang transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes AT tanqi transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes AT jiajinping transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes AT xieping transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes AT lijunai transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes AT wangminghua transcriptionalprofilesrevealhistologicoriginandprognosisacross33thecancergenomeatlastumortypes |